Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma

被引：4
|
作者：
Giaccone, L. [1 ,2 ]
Festuccia, M. [3 ]
Zallio, F. [4 ]
Sorasio, R. [5 ]
Brunello, L. [2 ,3 ]
Maffini, E. [1 ,2 ]
Dellacasa, C. [1 ]
Passera, R. [6 ]
Iovino, G. [7 ]
Aydin, S. [7 ]
Boccadoro, M. [2 ,3 ]
Vitolo, U. [7 ]
Mordini, N. [5 ]
Pini, M. [4 ]
Busca, A. [1 ]
Bruno, B. [1 ,2 ]
机构：
[1] AOU Citta Salute & Sci Torino, Dipartimento Oncol, SSD Trapianto Allogen Cellule Staminali, Turin, Italy
[2] Univ Torino, Scuola Med, Dipartimento Biotecnol Mol & Sci Salute, Turin, Italy
[3] AOU Citta Salute & Sci Torino, Dipartimento Oncol, Ematol U, Turin, Italy
[4] AO Antonio & Biagio & C Arrigo, SS Trapianti SC Ematol, Alessandria, Italy
[5] AO Santa Croce & Carle, UO Ematol, Cuneo, Italy
[6] AOU Citta Salute & Sci Torino, Div Med Nucl 2, Turin, Italy
[7] AOU Citta Salute & Sci Torino, Dipartimento Oncol, Ematol, Turin, Italy
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷 / 08期
关键词：
BRENTUXIMAB VEDOTIN; REDUCED-INTENSITY; MARROW-TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; EUROPEAN GROUP; WORKING PARTY; EXPERIENCE; BLOOD; REGIMEN;
D O I：
10.1038/bmt.2017.99
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1208 / 1211
页数：4
相关论文
共 50 条
  • [1] Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma
    L Giaccone
    M Festuccia
    F Zallio
    R Sorasio
    L Brunello
    E Maffini
    C Dellacasa
    R Passera
    G Iovino
    S Aydin
    M Boccadoro
    U Vitolo
    N Mordini
    M Pini
    A Busca
    B Bruno
    Bone Marrow Transplantation, 2017, 52 : 1208 - 1211
  • [2] Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation
    Link, C. S.
    Mies, F.
    Scheele, J.
    Kramer, M.
    Schetelig, J.
    Ordemann, R.
    Haenel, M.
    Bornhaeuser, M.
    Ehninger, G.
    Kroschinsky, F.
    BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1527 - 1529
  • [3] Long-term follow-up of patients with relapsed or refractory non-Hodgkin’s lymphoma receiving allogeneic stem cell transplantation
    C S Link
    F Mies
    J Scheele
    M Kramer
    J Schetelig
    R Ordemann
    M Hänel
    M Bornhäuser
    G Ehninger
    F Kroschinsky
    Bone Marrow Transplantation, 2016, 51 : 1527 - 1529
  • [4] Long term follow-up after autologous stem cell transplantation in refractory or relapsed Hodgkin lymphoma
    Stamatoullas, A.
    Lanic, H.
    Contentin, N.
    Nunes, K.
    Picquenot, J. M.
    Bastard, C.
    Tilly, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 78 - 78
  • [5] Long-term follow-up of patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed or refractory follicular lymphoma
    Hashida, Risa
    Kato, Jun
    Okamoto, Shinichiro
    Mori, Takehiko
    BONE MARROW TRANSPLANTATION, 2018, 53 : 280 - 281
  • [6] LONG-TERM FOLLOW-UP OF REDUCED-INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY OR RELAPSED FOLLICULAR LYMPHOMA
    Mori, T.
    Ono, Y.
    Kato, J.
    Yamane, A.
    Okamoto, S.
    HAEMATOLOGICA, 2012, 97 : 717 - 718
  • [7] Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma
    Ono, Yukako
    Mori, Takehiko
    Kato, Jun
    Yamane, Akiko
    Shimizu, Takayuki
    Kikuchi, Taku
    Kohashi, Sumiko
    Okamoto, Shinichiro
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 929 - 931
  • [8] Long-term follow up of patients with relapsed non-Hodgkin lymphoma receiving allogeneic stem cell transplantation
    Link, C.
    Mies, F.
    Kramer, M.
    Schetelig, J.
    Haenel, M.
    Bornhaeser, M.
    Ehninger, G.
    Kroschinsky, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 132 - 132
  • [9] The role of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma - a long-term follow-up single center experience
    Roerden, M.
    Soekler, M.
    Kanz, L.
    Bethge, W.
    Vogel, W.
    Walz, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 163 - 163
  • [10] Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience
    Malte Roerden
    Martin Sökler
    Lothar Kanz
    Wolfgang Bethge
    Wichard Vogel
    Juliane S. Walz
    Annals of Hematology, 2020, 99 : 265 - 276
12345